Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
03/20/2014 | US20140081017 Histone Deacetylase Inhibitors for Enhancing Activity of Antifungal Agents |
03/20/2014 | US20140080860 Novel hybrid cholinesterase inhibitors |
03/20/2014 | US20140080802 Inhibitors of Histone Deacetylase |
03/20/2014 | US20140077165 Organic compound and organic light emitting device using the same |
03/19/2014 | EP2709181A1 Light-emitting element material and light-emitting element |
03/19/2014 | EP2707347A1 Processes and intermediates |
03/19/2014 | EP2707346A1 Process for the preparation of protease inhibitors |
03/19/2014 | CN103649049A Substituted 3-(biphenyl-3-yl)-8,8-difluoro-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy and halogen-substituted spirocyclic ketoenols |
03/19/2014 | CN103649048A Indoleamine derivatives for the treatment of central nervous system diseases |
03/19/2014 | CN103649047A Novel processes for the preparation of prostaglandin amides |
03/19/2014 | CN103641770A Spirofluorene derivative, material for light-emitting element, light-emitting element, light-emitting device, and electronic device |
03/19/2014 | CN103641769A Preparation method of isoindoline hydrochloride |
03/19/2014 | CN103641768A Phenylindole high iodine salt compound, and preparation method and use thereof |
03/19/2014 | CN103641767A Substituted phenylindolyl selenide, selenoxide, selenone and application as tumor cell proliferation inhibitor |
03/19/2014 | CN103641766A Method for continuously extracting L-tryptophan from fermentation liquor |
03/19/2014 | CN103641765A Modulators of ATP-binding cassette transporters |
03/19/2014 | CN102351777B Preparation method for chiral 3-hydroxyl-3-methylene nitro indole-2-ketone derivative |
03/19/2014 | CN102131777B Piperidyl acrylamide antogonists of CCR2 |
03/19/2014 | CN102070383B Method for preparing 1,2-diketone by performing catalytic oxidation on olefin |
03/18/2014 | US8673957 Fluorescent probe |
03/18/2014 | US8673909 Indole compounds and methods for treating visceral pain |
03/18/2014 | US8673904 Epoxide inhibitors of cysteine proteases |
03/18/2014 | US8673818 C2-phenyl-substituted cyclic ketonols |
03/18/2014 | CA2768682C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
03/18/2014 | CA2754085C Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same |
03/18/2014 | CA2629077C Novel process for the preparation of thoc |
03/13/2014 | WO2014038867A1 A novel combination of a host compound and a dopant compound and an organic electroluminescence device comprising the same |
03/13/2014 | WO2014038677A1 Novel aromatic heterocyclic derivative, organic electroluminescent element material, organic electroluminescent element material solution, and organic electroluminescent element |
03/13/2014 | WO2014037900A1 Indole carboxamide derivatives and uses thereof |
03/13/2014 | WO2014037307A1 Process for preparing 6-iodo-2-oxindole |
03/13/2014 | WO2013190509A3 Preparation of intermediates of boceprevir |
03/13/2014 | WO2013190497A3 Compositions and methods for treatment of inflammatory diseases of the lung |
03/13/2014 | WO2013178682A3 Multicomponent process for the preparation of bicyclic compounds |
03/13/2014 | US20140072515 Cyanine compounds |
03/13/2014 | US20140072512 Perylenequinone derivatives and uses thereof |
03/12/2014 | EP2704570A1 Drug substances, pharmeceutical compositions and methods for preparing the same |
03/12/2014 | CN103627748A Preparation method of indirubin derivative and product and application thereof |
03/12/2014 | CN103626714A Method for synthesizing alpha-amino ketone from ketone and imine |
03/12/2014 | CN103626688A Organic semiconductor material, preparation method of organic semiconductor material and electroluminescent device |
03/12/2014 | CN103626666A Soluble triphenylamine type organic micromolecular hole transport material and preparation method and application thereof |
03/12/2014 | CN102898343B Method for preparing poly-substituted pyrrole derivatives |
03/12/2014 | CN102863373B Method for synthesizing 5-benzylazaspiro[2,4]heptane |
03/12/2014 | CN102675144B Jasmonate hormone analogs and preparation method and application thereof |
03/12/2014 | CN102516153B 5-fluoroindole-2-one-3-carbamide compounds, preparation method thereof and application thereof |
03/12/2014 | CN102143980B Polymers functionalized with imide compounds containing protected amino group |
03/12/2014 | CN101987822B Organic electroluminescent material and application thereof |
03/11/2014 | US8669374 Functionalized cyanine dyes (PEG) |
03/11/2014 | US8669373 Carbazole derivative and method for producing the same |
03/06/2014 | WO2014035149A1 N-acylhydrazone derivatives for selective t cell inhibitor and anti-lymphoid malignancy drug |
03/06/2014 | WO2014034791A1 Organic electroluminescent element |
03/06/2014 | WO2014006569A3 Saxagliptin salts |
03/06/2014 | WO2013144931A3 Tcr/mhcii-collagen interaction inhibitors useful for the treatment of rheumatoid arthritis |
03/06/2014 | WO2013063468A8 Amino acid derivates functionalized on the n- terminal capable of forming drug incapsulating microspheres |
03/06/2014 | US20140066634 Process for preparing 6-iodo-2-oxindole |
03/06/2014 | US20140066408 Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives |
03/06/2014 | US20140066407 Fungicide Active Substance Combinations |
03/06/2014 | DE102012017516A1 New 1-aryloxy-3-pyrrol-1-yl-propan-2-one derivatives are cytosolic phospholipase A2 inhibitors, useful for prophylactic or therapeutic treatment of diseases caused by increased activity of phospholipase A2, preferably e.g. pain and fever |
03/05/2014 | EP2702038A1 Synthesis of hydroxyalkyl amides from esters |
03/05/2014 | CN103620808A Organic electroluminescent element |
03/05/2014 | CN103620806A Light emitting element material and light emitting element |
03/05/2014 | CN103619815A Method for producing proline compound |
03/05/2014 | CN103613592A Synthesis method of aromatic ring or aromatic heterocyclic ring-fused amide |
03/05/2014 | CN103613478A Synthetic method of alpha-hydroxyl carbonyl compound |
03/05/2014 | CN102083790B Spiro(5.5)undecane derivatives |
03/05/2014 | CN102046595B Substituted 4-aminocyclohexane derivatives |
03/05/2014 | CN101805281B Oxime ester compound and photosensitive polymer composition using same |
03/04/2014 | US8664443 Process for the preparation of (1S, 3S, 5S)-2-[2(S)-2-amino-2-(3-hydroxy-1-adamantan-1-yl) acetyl]-2-azabicyclo [3.1.0] hexane-3-carbonitrile |
03/04/2014 | US8664408 Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]proxy}benzamide hydrochloride and pharmaceutical compositions containing it |
03/04/2014 | US8664407 Chemical linkers with single amino acids and conjugates thereof |
03/04/2014 | US8664406 Fluorescent probe compounds, preparation method and use thereof |
03/04/2014 | US8664262 Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan |
03/04/2014 | US8664261 Organic compounds having cooling properties |
03/04/2014 | US8664218 Pharmaceutical compounds |
03/04/2014 | US8664213 Spiro bicyclic diamine derivatives as HIV attachment inhibitors |
02/27/2014 | WO2014031784A1 Compounds for the treatment of paramoxyvirus viral infections |
02/27/2014 | WO2014031125A1 Pro-neurogenic compounds |
02/27/2014 | WO2014029888A2 Branched or macrocyclic polyamines and uses thereof |
02/27/2014 | WO2014029498A1 Bixiamycins and sulfonylbixiamycins |
02/27/2014 | US20140058116 Process for preparing inhibitors of the hepatitis c virus |
02/27/2014 | US20140058106 System for fluorinating organic compounds |
02/27/2014 | US20140057959 Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these |
02/27/2014 | US20140057909 Novel Indole Derivative or Pharmaceutically Acceptable Salt Thereof, Preparation Method Thereof, and Pharmaceutical Composition for Preventing or Treating Metabolic Diseases Containing Same as Active Ingredient |
02/27/2014 | US20140057900 Pro-Neurogenic Compounds |
02/26/2014 | EP2700631A1 A model for glutamate racemase inhibitors and glutamate racemase antibacterial agents |
02/26/2014 | CN103601668A Preparation method of N-phenyl-3-bromocarbazole |
02/26/2014 | CN103601667A Method for isolating carbazole from anthracene oil |
02/26/2014 | CN103601666A Preparation method of octahydrocyclopentane[C]pyrrole |
02/26/2014 | CN103601665A Method of extracting amino acid by aqueous two phase system based on ionic liquid |
02/26/2014 | CN103601664A Method for separating tryptophan through liquid-liquid extraction by using ionic liquid |
02/26/2014 | CN103601663A Tryptamine derivative compound and preparation method and purpose thereof |
02/26/2014 | CN103601662A Melatonin hapten and melatonin complete antigen as well as preparation methods and applications thereof |
02/26/2014 | CN101659593B Organic electroluminescent compound and organic electroluminescent device using the same |
02/25/2014 | US8658839 Oxidation of hydrocarbons |
02/25/2014 | US8658804 Process for preparing N-substituted cyclic imides |
02/25/2014 | US8658803 Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators |
02/25/2014 | CA2404868C C2-phenyl-substituted cyclic keto-enols as pesticides and herbicides |
02/20/2014 | WO2014027676A1 Organic electroluminescence element |
02/20/2014 | WO2014026882A1 Azaheterocycles as bir2 and/or bir3 inhibitors |
02/20/2014 | WO2014002114A3 Process for preparation of saxagliptin and hydrates thereof |
02/20/2014 | WO2013100539A9 Compound for organic optoelectronic device, organic light emitting element including same, and display device including said organic light emitting element |